Oligonucleotides are artificially synthesized short-chain nucleic acids that have been precisely designed and can intervene in the disease process at the genetic level. Protheragen is at the forefront of medical innovation, offering a series of oligonucleotides, which represent a revolutionary advancement from traditional small molecules and biopharmaceuticals to precise targeted therapies.

The products we provide cover the most mainstream categories of oligonucleotide drugs currently available, including antisense oligonucleotides (ASOs) and small interfering RNA (siRNA), which can be directly used for preclinical research, clinical trials, and commercial production. Our product portfolio is designed to empower global pharmaceutical and biotechnology companies to jointly develop breakthrough drugs.

Wide Range of Applications

• Inherited rare diseases
• Metabolic diseases
• Ophthalmic diseases
• Other fields

Product Features

• High purity and precise sequence

We employ advanced manufacturing techniques to ensure that each batch of products has outstanding purity and the correct nucleotide sequences, thereby guaranteeing the efficacy and safety of the final drug.

• Advanced chemical modification

The oligonucleotides we provide adopt key chemical modification technologies that have been clinically verified, significantly enhancing the stability of the products, prolonging their half-life, and improving their pharmacokinetic properties.

We believe that oligonucleotide therapy is one of the core pillars of the future of medicine. We are constantly expanding our product portfolio, and there are many products that have not been listed. If you cannot find the product you need in our catalog or require more detailed information, please contact us. We will get back to you within 2-4 working days.